MRNA
Income statement / Annual
Last year (2024), Moderna, Inc.'s total revenue was $3.20 B,
a decrease of 53.29% from the previous year.
In 2024, Moderna, Inc.'s net income was -$3.56 B.
See Moderna, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$3.20 B |
$6.85 B |
$18.88 B |
$17.74 B |
$803.40 M |
$60.21 M |
$135.07 M |
$205.83 M |
$108.40 M |
| Cost of Revenue |
$1.46 B
|
$4.69 B
|
$5.42 B
|
$2.62 B
|
$39.18 M
|
$31.02 M
|
$24.86 M
|
$20.54 M
|
$15.11 M
|
| Gross Profit |
$1.74 B
|
$2.16 B
|
$13.46 B
|
$15.12 B
|
$764.21 M
|
$29.19 M
|
-$319.01 M
|
$185.29 M
|
$93.28 M
|
| Gross Profit Ratio |
0.54
|
0.31
|
0.71
|
0.85
|
0.95
|
0.48
|
-2.36
|
0.9
|
0.86
|
| Research and Development Expenses |
$4.54 B
|
$4.85 B
|
$3.30 B
|
$1.99 B
|
$1.37 B
|
$496.31 M
|
$454.08 M
|
$410.46 M
|
$274.72 M
|
| General & Administrative Expenses |
$0.00
|
$1.35 B
|
$1.01 B
|
$0.00
|
$0.00
|
$109.62 M
|
$94.25 M
|
$64.72 M
|
$57.45 M
|
| Selling & Marketing Expenses |
$0.00
|
$204.00 M
|
$121.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.17 B
|
$1.55 B
|
$1.13 B
|
$567.00 M
|
$188.27 M
|
$109.62 M
|
$94.25 M
|
$64.72 M
|
$57.45 M
|
| Other Expenses |
-$37.00 M
|
$0.00
|
-$388.00 M
|
-$735.00 M
|
-$31.25 M
|
-$31.02 M
|
-$454.08 M
|
-$20.54 M
|
-$15.11 M
|
| Operating Expenses |
$5.68 B
|
$6.39 B
|
$4.04 B
|
$1.82 B
|
$1.53 B
|
$574.91 M
|
$94.25 M
|
$454.64 M
|
$317.05 M
|
| Cost And Expenses |
$7.14 B
|
$11.09 B
|
$9.46 B
|
$4.44 B
|
$1.57 B
|
$606.00 M
|
$603.93 M
|
$475.18 M
|
$332.17 M
|
| Interest Income |
$425.00 M
|
$421.00 M
|
$200.00 M
|
$18.00 M
|
$24.72 M
|
$38.53 M
|
$27.02 M
|
$15.24 M
|
$11.31 M
|
| Interest Expense |
$24.00 M
|
$38.00 M
|
$29.00 M
|
$18.00 M
|
$9.89 M
|
$6.61 M
|
$3.10 M
|
$132.00 K
|
$0.00
|
| Depreciation & Amortization |
$189.00 M
|
$621.00 M
|
$348.00 M
|
$232.00 M
|
$31.25 M
|
$31.02 M
|
$24.86 M
|
$20.54 M
|
$15.11 M
|
| EBITDA |
-$3.39 B |
-$3.28 B |
$9.77 B |
$13.53 B |
-$703.38 M |
-$477.08 M |
-$412.05 M |
-$235.33 M |
-$208.66 M |
| EBITDA Ratio |
-1.06
|
-0.48
|
0.52
|
0.76
|
-0.88
|
-7.92
|
-3.05
|
-1.14
|
-1.92
|
| Operating Income Ratio |
-1.23
|
-0.62
|
0.5
|
0.75
|
-0.95
|
-9.06
|
-3.47
|
-1.31
|
-2.06
|
| Total Other Income/Expenses Net |
$338.00 M
|
$297.00 M
|
$155.00 M
|
-$11.00 M
|
$18.63 M
|
$31.00 M
|
$28.86 M
|
$13.36 M
|
$8.60 M
|
| Income Before Tax |
-$3.61 B
|
-$3.94 B
|
$9.58 B
|
$13.29 B
|
-$744.51 M
|
-$514.72 M
|
-$440.01 M
|
-$256.00 M
|
-$215.17 M
|
| Income Before Tax Ratio |
-1.13
|
-0.58
|
0.51
|
0.75
|
-0.93
|
-8.55
|
-3.26
|
-1.24
|
-1.99
|
| Income Tax Expense |
-$46.00 M
|
$772.00 M
|
$1.21 B
|
$1.08 B
|
$2.55 M
|
-$695.00 K
|
$326.00 K
|
-$80.00 K
|
$1.04 M
|
| Net Income |
-$3.56 B
|
-$4.71 B
|
$8.36 B
|
$12.20 B
|
-$747.06 M
|
-$514.02 M
|
-$384.73 M
|
-$255.92 M
|
-$216.21 M
|
| Net Income Ratio |
-1.11
|
-0.69
|
0.44
|
0.69
|
-0.93
|
-8.54
|
-2.85
|
-1.24
|
-1.99
|
| EPS |
-9.27 |
-12.34 |
21.26 |
30.31 |
-1.96 |
-1.55 |
-1.17 |
-0.72 |
-3.79 |
| EPS Diluted |
-9.27 |
-12.34 |
20.1 |
28.29 |
-1.96 |
-1.55 |
-1.17 |
-0.72 |
-3.79 |
| Weighted Average Shares Out |
$384.00 M
|
$382.00 M
|
$394.00 M
|
$403.00 M
|
$381.33 M
|
$330.80 M
|
$328.80 M
|
$376.00 M
|
$64.09 M
|
| Weighted Average Shares Out Diluted |
$384.00 M
|
$382.00 M
|
$416.00 M
|
$431.00 M
|
$381.33 M
|
$330.80 M
|
$328.80 M
|
$376.00 M
|
$64.09 M
|
| Link |
|
|
|
|
|
|
|
|
|
